Engflag

Laxamin

Quick links to important sections

Laxamin

There is no image.

Method of action: Laxative

Treatment option: Constipation, Proctitis

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Laxamin

What is Laxamin?

Laxamin is a pharmacological agent primarily utilized in the management of constipation. It belongs to the class of medications known as stimulant laxatives. The active component in Laxamin works by interacting with the intestinal lining to facilitate bowel movements.

Mechanism of Action

The primary function of Laxamin is to stimulate the enteric nerves within the walls of the colon. This stimulation increases peristalsis, which is the series of wave-like muscle contractions that move waste through the digestive tract. By accelerating this process, the medication reduces the transit time of stool, making evacuation more frequent and effective.

In addition to promoting muscle contractions, Laxamin influences the transport of water and electrolytes across the intestinal mucosa. By increasing the accumulation of fluid within the intestinal lumen, it softens the stool, further aiding its passage.

Indications and Use

Laxamin is typically indicated for the short-term relief of occasional constipation. It is also used in clinical settings where complete evacuation of the bowel is required, such as prior to certain medical examinations or surgical procedures involving the gastrointestinal tract.

Key characteristics of its application include:

  • Acute Constipation: Providing relief when lifestyle modifications, such as increased fiber intake or hydration, have not produced sufficient results.
  • Diagnostic Preparation: Assisting in clearing the colon to ensure clear visualization during endoscopic or radiological procedures.

Formulations

Laxamin is available in several forms to accommodate different clinical needs and patient preferences. Common formulations include oral tablets and rectal suppositories. The choice of formulation often depends on the required onset of action, as rectal applications generally produce results more rapidly than oral versions.

What side effects are possible with Laxamin?

Laxamin: Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety profile of Laxamin, strictly based on regulatory classification standards (such as those from the EMA or FDA).

Frequency-Classified Adverse Reactions

Side effects are classified by how often they occurred in clinical studies and post-marketing surveillance:

Classification Incidence Rate (Approximate) Example Reactions (Non-Exhaustive)
Very Common ge 1 in 10 patients Abdominal pain, flatulence, diarrhea
Common ge 1 in 100 to < 1 in 10 patients Nausea, mild headache
Uncommon ge 1 in 1,000 to < 1 in 100 patients Vomiting, rash, dizziness
Rare ge 1 in 10,000 to < 1 in 1,000 patients Anaphylactic reaction, Ischaemic colitis
Not Known Frequency cannot be estimated Severe electrolyte disturbances

Body Systems Affected (System Organ Classes)

Adverse reactions have been formally documented across several body systems, including Gastrointestinal Disorders, Nervous System Disorders, Immune System Disorders, Skin and Subcutaneous Tissue Disorders, and Metabolism and Nutrition Disorders.

Serious Adverse Reactions

Clinically significant adverse reactions, though often rare, that are documented in the official labeling include Severe Hypersensitivity Reactions (such as anaphylaxis) and significant, acute Electrolyte Disturbances (e.g., severe hypokalaemia).

Safety Restrictions and Monitoring

Laxamin is formally contraindicated in patients with known or suspected gastrointestinal obstruction or Toxic Megacolon. The official label specifies that diarrhea is more prevalent during the initial period of dose titration. Additionally, monitoring of serum electrolytes is required in patients with pre-existing cardiac, renal, or hepatic impairment, or in those taking diuretics, as these conditions may increase the risk of serious side effects.

Overdose and Emergency Response

The official regulatory documentation for Laxamin (Sodium Picosulfate) details the manifestations of acute and chronic overexposure, focusing primarily on disturbances to fluid and electrolyte balance.

Overdose Classification Documented Manifestations
Acute Overdose Profuse diarrhoea, severe abdominal cramps, and clinically significant fluid and electrolyte loss (hypokalaemia).
Chronic Overdosage Persistent abdominal pain, hypokalaemia, renal calculi (kidney stones), secondary hyperaldosteronism, and renal tubular damage.
Emergency Action Required Required Management Focus
Seek immediate medical attention or contact a poison control center at once. Symptomatic and supportive treatment with prompt correction of fluid and electrolyte imbalance.

In instances of acute overdosage, the excessive stimulant action can result in rapid dehydration and severe hypokalaemia, which may, in rare and severe cases, lead to outcomes like seizures or coma. The regulatory profile notes that the urgent correction of fluid and electrolyte imbalance is especially critical for the young and the elderly. Supportive measures described in official labeling include replacement of fluids, continuous electrolyte monitoring, and administration of antispasmodics. If ingestion was recent, procedures such as gastric lavage may be considered to prevent further absorption.

Therapeutic Uses of Laxamin

What Laxamin Treats: Main Uses and Benefits

Laxamin (Sodium Picosulfate) is commonly used to help manage symptoms and is relevant across therapeutic areas where additional symptomatic support of the lower digestive tract is needed. The medication is generally used for the short-term relief of occasional constipation.

The therapeutic benefit is relevant for easing symptoms related to physical discomfort, commonly used to help with infrequent bowel movements, straining, and the discomfort linked to passing hard stools. It is relevant for easing symptomatic manifestations in conditions characterized by episodic or fluctuating symptoms, or when predictable evacuation may be appropriate before diagnostic procedures or surgery.

“Its application is relevant for providing supportive relief, which contributes to easing the overall symptom load when symptoms related to physical discomfort interfere with daily functioning.”

Quick Facts: Indications & Symptom Relief

Category Description
Relevant for Short-term symptomatic relief of occasional constipation.
Symptom Focus Symptoms that create noticeable physiological strain, such as infrequent movements, physical straining, and hard stool discomfort.
Clinical Scenarios Commonly used when short-term symptomatic assistance is needed, such as bowel preparation for procedures, or to minimize strain in at-risk groups.
Patient Benefit Supports easing distress and assists with maintaining functional stability when symptoms are more noticeable.

Eligibility and Restrictions for Use

Who Can and Cannot Use Laxamin?

Laxamin (Sodium Picosulfate) is officially approved for use in the adult population and in pediatric patients 9 years of age and older for specialized procedures.

Populations for Whom Use is Contraindicated

Use is prohibited for individuals with several critical health conditions, as explicitly stated in regulatory labeling. These include:

  • Severe renal impairment (creatinine clearance less than 30 mL/minute).
  • Conditions compromising the integrity of the gastrointestinal tract, such as bowel perforation, ileus, gastrointestinal obstruction, toxic colitis, toxic megacolon, or gastric retention.
  • Severe dehydration or congestive heart failure.
  • Known hypersensitivity to the active substance.

Populations Requiring Restriction or Caution

Use is not recommended or requires medical supervision for:

  • Children younger than 10 or 12 years of age for general relief (use is not established or restricted).
  • Pregnant or breastfeeding individuals (limited clinical experience; use is not recommended unless benefit outweighs risk).

Caution is advised for older adults, patients with pre-existing electrolyte disturbances, mild-to-moderate renal impairment, or those at risk of cardiac arrhythmias.

Connection to the overall eligibility profile Official regulatory documents define eligibility by creating absolute prohibitions for conditions incompatible with the drug’s mechanism, focusing heavily on protecting patients from acute fluid/electrolyte shifts and intestinal injury. Restrictions are also set by specific age thresholds and reproductive status due to limited data or increased patient vulnerability.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies specific patterns regarding co-administration of Sodium Picosulfate (Laxamin) with other substances, primarily concerning pharmacokinetic alterations and pharmacodynamic additive effects. The rapid gastrointestinal transit induced by this medicine may lead to reduced absorption of many orally administered drugs, which is a pharmacokinetic interaction pattern documented in government sources.

Timing and Efficacy Interactions

This concern over reduced exposure necessitates a mandatory timing rule for certain oral medications. General oral medications should not be administered within one hour of starting Laxamin. Specific high-risk oral medications, including Tetracycline and Fluoroquinolone antibiotics, Iron supplements, and Digoxin, require a wider separation, mandated as at least two hours before and not less than six hours after administration. Concomitant use of antibiotics may also reduce Laxamin's own efficacy by altering the colonic bacterial flora required to activate the pro-drug.

Additive Effects and Restrictions

Pharmacodynamic interactions exist with other substance classes. Co-administration with Diuretics or Corticosteroids increases the officially documented risk of fluid and electrolyte disturbances, particularly hypokalemia. Furthermore, the use of other oral laxatives is restricted during treatment due to the potential for an excessive additive effect. Caution is also noted regarding alcohol consumption, which may increase the risk of certain adverse effects. For specialized use, the combination product is contraindicated in patients with severely reduced renal function due to the risk of accumulation from associated components.

Mechanism of Action

Pro-drug Activation Confines Action to the Colon

Laxamin (Sodium Picosulfate) is initially inert, requiring a biological trigger to become active. The molecule must first reach the large intestine where colonic bacterial sulfatase performs enzymatic hydrolysis, converting the inactive pro-drug into the active metabolite, BHPM. This conversion process confines the drug's mechanism of action to the lower gastrointestinal tract, with the activation and transit time (typically 6–12 hours) dictating the onset of the physiological effect.

Dual Mechanism: Stimulating Motility and Altering Fluid Balance

Once activated, BHPM exerts two simultaneous effects. First, it directly stimulates the sensory nerve endings and smooth muscle within the colonic wall, increasing the strength and frequency of propulsive muscle contractions. Second, BHPM acts on the colonic mucosa to inhibit the reabsorption of water and electrolytes, while promoting their secretion into the lumen. This combined motor and fluidizing action increases colonic propulsive forces and alters intraluminal fluid dynamics, which facilitates the physiological event of emptying the lower bowel.

Dosage and Administration Information

Laxamin (polyethylene glycol 3350) is an osmotic laxative available as a powder for oral solution, typically used to treat occasional constipation. It works by retaining water in the stool, which softens it and increases bowel movement frequency.

Administration and Dosage

Laxamin should be taken once a day as directed on the product label or by a healthcare provider. The standard adult dose for occasional constipation is 17 grams of powder.

Step Instruction Detail
1. Measure Use the measuring cap provided to measure one dose (17 grams). If using a single-dose packet, use the entire contents. Ensure the cap is filled to the indicated line.
2. Mix Pour the powder into a cup containing 4 to 8 ounces (120 to 240 mL) of a beverage. Water, juice, soda, coffee, or tea are suitable liquids. Do not mix with starch-based thickeners.
3. Dissolve & Drink Stir the mixture well until the powder is fully dissolved, and drink the solution immediately. Do not drink if there are undissolved clumps of powder. Do not save the solution for later use.

Laxamin can be taken at any time of day, with or without food. It may take one to three days to produce a bowel movement. Do not use this product for more than seven days unless specifically advised by a healthcare professional, as prolonged use may require medical supervision. If constipation persists or worsens after one week, contact your doctor. It is essential to stay well-hydrated while taking this medication.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Overview of Clinical Trials

Laxamin is a combination therapy involving two established agents. Clinical research evaluated whether the drug influenced clinical symptoms and quality of life in adults. Studies examined whether the combination was associated with a change in pain and the speed of symptom resolution.

The combination therapy was studied in most adult patients who fit specific inclusion criteria. The research typically focused on the acute and short-term period.

Key Findings from Major Trials

  • Symptom Resolution: Clinical studies primarily assessed outcomes over a 7-day period. The primary endpoint of the pivotal trial was the change in a validated symptom scale. The results reported an observable difference in symptoms between the group receiving the study drug and the placebo group.
  • Pain Relief: Pain was typically measured using a visual analogue scale (VAS). Trials explored the extent to which the combination was associated with a decrease in reported pain scores. Studies have reported findings regarding the duration of any change in symptom severity.
  • Tolerability and Side Effects: The tolerability profile was evaluated as part of all major trials. Specific rates of study discontinuation were reported in the main studies.

Pharmacological Research

  • Mechanism of Action: The drug consists of two components: Agent A and Agent B. The evaluation of the combination of the two agents was the focus of one study. The results indicate that research examined the hypothesis that the drug influences symptoms through its constituent agents.
  • Comparison to Other Treatments: Other studies evaluated the drug's effect in comparison to other treatments. These comparative trials were often open-label (participants knew which treatment they were receiving).

Dosage and Safety Profile

  • Dosage Regimen: The trials utilized a fixed-dose combination of the two agents. The study procedures included a specific administration schedule to assess patient tolerability.

Frequently Asked Questions (FAQ)

Common questions about Laxamin (FAQ)

Q: What is Laxamin and what is it used for?

A: Laxamin (active ingredient: Polyethylene Glycol 3350) is an osmotic laxative. It works by drawing water into the stool, making it softer and easier to pass. It is primarily used to treat occasional constipation in adults and children 17 years of age and older.

Q: How long does it take for Laxamin to work?

A: Laxamin generally produces a bowel movement in 1 to 3 days. It does not typically produce an immediate effect. It is important to continue using the product as directed for a few days to see the full effect.

Q: How should I take Laxamin?

  • Dosing: The usual adult dose is 17 grams of powder (one level capful) dissolved in 4 to 8 ounces of a beverage.
  • Preparation: The powder should be mixed and fully dissolved in water, juice, soda, coffee, or tea.
  • Timing: Take it once per day.
  • Duration: Do not use Laxamin for more than 7 days unless directed by a healthcare professional.

Q: What are the common side effects of Laxamin?

  • The most common side effects are generally mild and related to the gastrointestinal system.
  • These may include bloating, gas (flatulence), nausea, stomach cramps, and diarrhea.
  • If you experience severe diarrhea or rectal bleeding, stop using Laxamin and contact a healthcare professional immediately.

Q: Can I take Laxamin if I have other medical conditions?

  • Do not take Laxamin if you have kidney disease, severe stomach pain, or if a healthcare professional has told you that you have a bowel obstruction.
  • Consult a healthcare professional before use if you have:
    • Irritable bowel syndrome (IBS)
    • Nausea, vomiting, or stomach pain
    • A sudden change in bowel habits that lasts more than 2 weeks
    • Been using a laxative product for more than 1 week.

How should Laxamin be stored and disposed of?

How to Store and Dispose of Laxamin

Official regulatory guidelines define specific conditions for the storage and final disposal of Laxamin (Sodium Picosulfate).

Storage Requirement Description
Temperature Store at controlled room temperature (typically 20 C to 25 C). The product must not be refrigerated or frozen.
Protection The medicine must be kept in its original package to ensure protection from moisture and direct light.
Child Safety It is required to keep Laxamin out of the sight and reach of children at all times.
Stability Limit For the solution form, the medicine must be used immediately after preparation or opening, and any unused portion must be discarded.
Disposal All unused or expired medicinal product and related waste material must be disposed of in accordance with local regulatory requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagArgentina

Equivalent of Laxamin found in:

A-Z Index: